Talk:Serum Institute of India

This is the talk page for discussing improvements to the Serum Institute of India article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

India: Maharashtra Mid‑importance

	India portal This article is within the scope of WikiProject India, which aims to improve Wikipedia's coverage of India-related topics. If you would like to participate, please visit the project page.IndiaWikipedia:WikiProject IndiaTemplate:WikiProject IndiaIndia articles
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by WikiProject Maharashtra (assessed as High-importance).

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Companies High‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

High This article has been rated as High-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

COVID-19 Low‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles
Low	This article has been rated as Low-importance on the project's importance scale.

Covid-19

The media is making it unclear who will be producing in the SII, in April astrazeneca was contracting for 1 billion doses, in May this changed to about 200 million doses. However, this was announced via the european commission not by astrazeneca, who has case files at the court of justice for cartel in the EU and several cases files at the US court of justice. There is now a national vaccine candidate that would be manufactured next month. There has also been news that oxford-astrazeneca is misusing trials in South-Africa, with vaccination campaigns on people from disadvantaged backgrounds. The WHO director and spokespersons have condemned the group for lacking beneficence and non-maleficence due to the recent events in trials in Africa. Therefore, it is unclear how the SII stands in regards to vaccine production with the pharmaceutical company. — Preceding unsigned comment added by 2A02:1811:2C21:F400:207D:6171:9F95:F532 (talk) 14:17, 3 July 2020 (UTC)[reply]